Monday, 3 November marked the start of #MedSafetyWeek 2025!
We’re proud to join forces with medicines regulatory authorities and partners from 118 countries worldwide to encourage the reporting of suspected side effects from medicines.
Medicines are continuously monitored to ensure their safety and reports form an essential part of global pharmacovigilance systems. These reports help regulatory agencies and pharmaceutical companies assess the safety of medicines after they have been placed on the market and throughout the product life cycle, improving patient safety worldwide.
We can all help make medicines safer. Learn more about the campaign here.
